Non-Current Liabilities
Total Liabilities
United Therapeutics Total Liabilities increased by 3.7% to $813.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.2%, from $936.70M to $813.10M. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -8.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026
How to read this metric
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
Detailed definition
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Peer comparison
Used across all industries to assess the overall debt burden relative to equity and assets.
Metric ID:
total_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $1.22B | $1.21B | $1.18B | $1.22B | $1.22B | $1.25B | $1.22B | $1.27B | $1.31B | $1.18B | $1.16B | $1.03B | $1.02B | $920.00M | $936.70M | $734.40M | $760.90M | $783.80M | $813.10M |
| QoQ Change | — | +1.1% | -0.7% | -2.2% | +3.5% | -0.4% | +2.3% | -2.0% | +3.9% | +3.2% | -9.9% | -2.1% | -11.3% | -0.4% | -10.0% | +1.8% | -21.6% | +3.6% | +3.0% | +3.7% |
| YoY Change | — | — | — | — | +1.6% | +0.0% | +3.1% | +3.3% | +3.7% | +7.6% | -5.3% | -5.4% | -19.2% | -22.1% | -22.2% | -19.0% | -28.4% | -25.6% | -14.8% | -13.2% |
Range$734.40M – $1.31B
CAGR-8.0%
Avg YoY Growth-9.7%
Median YoY Growth-9.3%
Current Streak3 quarters growth
Total Liabilities at Other Companies
Frequently Asked Questions
- What is United Therapeutics's total liabilities?
- United Therapeutics (UTHR) reported total liabilities of $813.10M in Q1 2026.
- How has United Therapeutics's total liabilities changed year-over-year?
- United Therapeutics's total liabilities decreased by 13.2% year-over-year, from $936.70M to $813.10M.
- What is the long-term trend for United Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), United Therapeutics's total liabilities has grown at a -8.5% compound annual growth rate (CAGR), from $1.22B to $783.80M.
- What does total liabilities mean?
- The total amount of money the company owes to all creditors and stakeholders.